Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5419]
News [12581]
Articles [170]
Editorials [5]
Conferences [246]
elearning [17]
Add panitumumab or bevacizumab to improve first-line metastatic colorectal...
Dr Fernardo Rivera - Hospital Universitario Marques de Valdecilla, Santander...
Add panitumumab or bevacizumab to improve first-line metastatic colorectal cancer therapy? ( Dr Fernardo Rivera - Hospital Universitario Marques de Valdecilla, Santander, Spain )
28 Sep 2015
Regional lymph node irradiation in early breast cancer
Prof Philip Poortmans - Radboud University Medical Center, Nijmegen, The...
Regional lymph node irradiation in early breast cancer ( Prof Philip Poortmans - Radboud University Medical Center, Nijmegen, The Netherlands )
28 Sep 2015
Hormonal suppression prevents ovarian failure, preserves fertility in women...
Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy
Hormonal suppression prevents ovarian failure, preserves fertility in women with breast cancer ( Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy )
28 Sep 2015
Post diagnosis aspirin improves survival in all gastrointestinal cancers
Ms Martine Frouws - Leiden University Medical Center, Leiden, Netherlands
Post diagnosis aspirin improves survival in all gastrointestinal cancers ( Ms Martine Frouws - Leiden University Medical Center, Leiden, Netherlands )
28 Sep 2015
Preventing ovarian failure and preserve fertility in women with breast cancer...
Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy
Preventing ovarian failure and preserve fertility in women with breast cancer with hormonal therapy ( Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy )
28 Sep 2015
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer:...
Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review ( Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK )
28 Sep 2015
PD-L2 expression and its relevance to anti-PD-1 therapy in cancer
Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA
PD-L2 expression and its relevance to anti-PD-1 therapy in cancer ( Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA )
28 Sep 2015
COMBI-V: Melanoma survival improved by targeted drug combination
Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France
COMBI-V: Melanoma survival improved by targeted drug combination ( Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France )
28 Sep 2015
Economics of radiotherapy and radiotherapy boost for high grade invasive breast...
Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands
Economics of radiotherapy and radiotherapy boost for high grade invasive breast cancer ( Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands )
28 Sep 2015
Prostate highlights from ECC 2015
Prof Noel Clarke and Dr Bertrand Tombal
Prostate highlights from ECC 2015 ( Prof Noel Clarke and Dr Bertrand Tombal )
27 Sep 2015
EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors...
Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland
EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors on long-term local control ( Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland )
27 Sep 2015
Cabozantinib improves advanced kidney cancer survival: METEOR trial results
Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Cabozantinib improves advanced kidney cancer survival: METEOR trial results ( Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
27 Sep 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation